Studies have demonstrated that in prostate cancer, CAFs overexpress GLUT1 and MCT4, increasing glycolysis and lactate export rates, while prostate cancer cells show decreased GLUT1 expression, reduced glucose uptake, and increased lactate uptake [108]. Here, SLC2A1 is linked to prostate carcinoma.